| Code | CSB-MP025833HU-WD2 |
| Abbreviation | Recombinant Human VEGFA protein (Active) |
| MSDS | |
| Size | Inquiry |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
VEGF165, the predominant pro-angiogenic isoform in human physiology, drives endothelial cell proliferation and migration through high-affinity binding to VEGFR-2, making quantitative control of receptor activation essential in vascular biology experiments. This mammalian-expressed protein, spanning the complete mature sequence (aa 27–191), demonstrates dose-dependent mitogenic activity in HUVEC proliferation assays with an ED50 of 0.2–10 ng/mL, providing a validated concentration range for angiogenesis models, wound healing studies, and stem cell differentiation protocols requiring precise VEGFR engagement. The mammalian expression system preserves native glycosylation patterns critical for receptor binding kinetics, supporting its use in surface plasmon resonance experiments, receptor-ligand competition assays, and antibody characterization workflows where post-translational fidelity directly impacts binding affinity measurements. Purity exceeding 95% by SDS-PAGE and endotoxin levels ≤10 EU/mg satisfy the quality thresholds commonly required for cell-based functional assays and in vivo tumor vascularization models.
There are currently no reviews for this product.